{
    "code": "02011618",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02011618",
    "time": "2020-02-25 09:57:04",
    "許可證字號": "衛署藥輸字第011618號",
    "註銷狀態": "已註銷",
    "註銷日期": "89\/10\/18",
    "註銷理由": "未展延而逾期者",
    "製造許可登錄編號": "",
    "有效日期": "81\/07\/21",
    "發證日期": "72\/07\/21",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201161808",
    "中文品名": "立必克注射劑５００公絲",
    "英文品名": "RELYOSIPTIC INJECTION",
    "適應症": "葡萄球菌、鏈球菌、肺炎雙球菌、腦膜炎球菌及其他具有感受性細菌引起之感染症",
    "劑型": "240乾粉注射劑",
    "包裝": "小瓶附溶液",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "HETACILLIN, LIDOCAINE HCL, EACH SOLVENT CONTAINS",
    "限制項目": "02輸　入",
    "申請商名稱": "1000201100  泰吉產業有限公司",
    "申請商地址": "台北巿撫遠街３９５巷１號１Ｆ",
    "主製造廠": [
        {
            "製造廠名稱": "FGR0027000  RELYO HELLAS LTD.",
            "製造廠廠址": "26  AGLOU CONSTANTINOU STR. ATHENS 107.",
            "製造廠公司地址": "",
            "製造廠國別": "GREECE",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812601000",
            "成分名稱": "HETACILLIN",
            "含量描述": "500",
            "含量": "500.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "7200001010",
            "成分名稱": "LIDOCAINE HCL",
            "含量描述": "0.052",
            "含量": "0.0520000000",
            "單位": "GM"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "9800001300",
            "成分名稱": "EACH SOLVENT CONTAINS",
            "含量描述": "6.5",
            "含量": "6.5000000000",
            "單位": "ML"
        }
    ]
}